Unlock stock picks and a broker-level newsfeed that powers Wall Street.

HKSE - Delayed Quote HKD

Dingdang Health Technology Group Ltd. (9886.HK)

Compare
0.335
+0.005
+(1.52%)
As of 10:53:40 AM GMT+8. Market Open.
Loading Chart for 9886.HK
  • Previous Close 0.330
  • Open 0.335
  • Bid 0.335 x --
  • Ask 0.345 x --
  • Day's Range 0.330 - 0.350
  • 52 Week Range 0.305 - 2.410
  • Volume 629,500
  • Avg. Volume 1,683,983
  • Market Cap (intraday) 442.022M
  • Beta (5Y Monthly) 1.31
  • PE Ratio (TTM) --
  • EPS (TTM) -0.300
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1.47

Dingdang Health Technology Group Ltd. operates as a service provider in the digital health on-demand business in the People's Republic of China. It offers a range of health products through offline retail and online direct sales channels. The company also offers online medical consultation through online and supplementary services; chronic diseases management; and health portfolio management and DOT medication adherence services. Dingdang Health Technology Group Ltd. was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China.

www.ddjkjt.com

2,363

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 9886.HK

View More

Performance Overview: 9886.HK

Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

9886.HK
33.00%
HANG SENG INDEX (^HSI)
6.68%

1-Year Return

9886.HK
68.69%
HANG SENG INDEX (^HSI)
28.91%

3-Year Return

9886.HK
97.29%
HANG SENG INDEX (^HSI)
0.55%

5-Year Return

9886.HK
97.29%
HANG SENG INDEX (^HSI)
11.37%

Compare To: 9886.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 9886.HK

View More

Valuation Measures

Annual
As of 4/14/2025
  • Market Cap

    435.43M

  • Enterprise Value

    -697.60M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.09

  • Price/Book (mrq)

    0.25

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -8.06%

  • Return on Assets (ttm)

    -4.72%

  • Return on Equity (ttm)

    -20.44%

  • Revenue (ttm)

    4.67B

  • Net Income Avi to Common (ttm)

    -376.5M

  • Diluted EPS (ttm)

    -0.300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.22B

  • Total Debt/Equity (mrq)

    9.08%

  • Levered Free Cash Flow (ttm)

    49.67M

Research Analysis: 9886.HK

View More

Company Insights: 9886.HK

Research Reports: 9886.HK

View More

People Also Watch